Skip to content
Home/Companies/HealthTech/Velocity Clinical Research
Velocity Clinical Research

Velocity Clinical Research

HealthTech·UK·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns Velocity Clinical Research?

Velocity Clinical Research is a British HealthTech company, currently owned by GHO Capital since 2021.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
GHO Capital
Investor
GHO Capital
GHO Capital III LP · 2021 · Buyout

Key facts

HQUK
SectorHealthTech
Websitevelocityclinical.com

More from GHO Capital III LP

Other portfolio companies in the same fund.

Alcami Corporation
Alcami Corporation
Active
PharmaUS· 2022
Sanner
Sanner
Active
MedTechGermany· 2022
Sapio Sciences
Sapio Sciences
Active
HealthTechUS· 2022
Biocare Medical
Biocare Medical
Exited 2026
MedTechUS· 2021
to Agilent Technologies
Clearview Healthcare Partners
Clearview Healthcare Partners
Active
Business ServicesUS· 2021
Envision Pharma
Active
HealthcareUK· 2021

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Advance Medical
Active
Summit PartnersUS
AdvancedMD
AdvancedMD
Active
Francisco PartnersUS
Agilio Software
Agilio Software
Active
TA AssociatesUS
agilon health
agilon health
Active
CD&RUS

Questions

Who owns Velocity Clinical Research?

Velocity Clinical Research is currently owned by GHO Capital, through GHO Capital III LP, since 2021.

When did GHO Capital acquire Velocity Clinical Research?

GHO Capital acquired Velocity Clinical Research in 2021.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue